Clinical Trials Logo

Filter by:
NCT ID: NCT04559815 Completed - Clinical trials for Diabetes Mellitus, Type 2

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical Practice

PIONEER REAL
Start date: November 8, 2020
Phase:
Study type: Observational

The purpose of the study is to collect information on how Rybelsus® works in people with type 2 diabetes and to see if Rybelsus® can lower participants blood sugar levels. Participants will get Rybelsus® as prescribed to them by their study doctor. The study will last for about 8-10 months. Participants will be asked to complete a questionnaire about how they take their Rybelsus® tablets. Participants will complete this questionnaire during their normally scheduled visit with the study doctor. Participants will be asked to complete some questionnaires about their diabetes treatment. Participants will complete these during their normally scheduled visits with the study doctor...

NCT ID: NCT04558177 Completed - Clinical trials for Geriatric In-patients

Repetitive Transcranial Stimulation to Treat Depression and Anxiety in Senior Inpatients

Start date: November 5, 2018
Phase: N/A
Study type: Interventional

Many seniors admitted for rehabilitation have symptoms of depression and anxiety that need to be treated before they can effectively engage in rehabilitation therapy. Anti-depressant or anti-anxiety medications are often used but there are many reasons why alternative or adjunctive treatments may be desirable. Medications can take weeks to become effective, if they work at all. There are many potential side effects of medications, especially in an older population, including cognitive and other neurologic impairments. There is also an increasing resistance to a polypharmacy approach to treatment in this population. A low-risk, relatively non-invasive, easily applied and well-tolerated treatment to accelerate mood and anxiety disorder resolution would allow earlier and more effective engagement in rehabilitation therapy. This would in turn shorten lengths of stay and improve quality of life. Recently, trans-cranial direct current stimulation with 1-2 mA currents has been proposed as a potential innovative alternative treatment modality. This stimulation is safe, easy to use, relatively insensitive to electrode placement, and may have other beneficial cognitive effects. The stimulation device consists of two electrodes placed on either side of the head, a unit that provides the stimulation and wires that connect this unit to the electrodes will be used. The electrodes are held in place with a head band.

NCT ID: NCT04557605 Completed - Hypoxemia Clinical Trials

Effects of a Face Mask on Oxygenation During Exercise

Start date: September 14, 2020
Phase: N/A
Study type: Interventional

There is concern that wearing a face mask during COVID will affect oxygen uptake, especially during intense exercise. This study will assess the effect of wearing two different face masks (disposable and cloth) on blood and muscle oxygenation during cycling exercise.

NCT ID: NCT04556734 Completed - Alopecia Areata Clinical Trials

Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata

Start date: July 29, 2020
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of etrasimod monotherapy (2 milligrams [mg] and 3 mg) in participants with moderate-to-severe alopecia areata (AA).

NCT ID: NCT04555343 Completed - Prostate Cancer Clinical Trials

Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retention

Start date: March 1, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

A study looking at the feasibility of doing a full-scale RCT that investigates the use of tranexamic acid intravesically prior to continuous bladder irrigation treatment in the emergency department for urinary retention due to clots. We want to know: - patient experience and acceptability of the intervention - study procedures (recruitment, site appropriateness, staff engagement) - safety data - identify resource use

NCT ID: NCT04555278 Completed - Clinical trials for Chronic Low-back Pain

Combining Non-invasive Brain Stimulation and Exercise to Treat Low Back Pain

Start date: September 25, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the efficacy of repetitive transcranial magnetic stimulation alone and in combination with motor control exercises on pain and disability for patients with chronic non-specific low back pain.

NCT ID: NCT04554667 Completed - Clinical trials for Cancer of Head and Neck

Heavy Lifting Strength Training in Head and Neck Cancer Survivors

LIFTING
Start date: November 24, 2020
Phase: Phase 1
Study type: Interventional

The LIFTING trial will examine the feasibility and safety of a heavy lifting strength training (HLST) program in head and neck cancer survivors (HNCS) at least 1 years post surgical neck dissection. The trial will determine whether this training style is safe and feasible in HNCS. Physical and psychosocial changes will also be reported.

NCT ID: NCT04551352 Completed - Uveal Melanoma Clinical Trials

A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas

Start date: October 28, 2020
Phase: Phase 1
Study type: Interventional

This is a first-in-human, multi-center clinical study to determine the safety, Maximum Tolerated Dose (MTD) and/or Optimal Biological Dose (OBD) as well as the optimal schedule for intravenous (IV) and/or subcutaneous (SC) administrations of RO7293583 with or without obinutuzumab pretreatment, in participants with unresectable metastatic TYRP1-positive melanomas who have progressed on standard of care (SOC) treatment, are intolerant to SOC, or are non-amenable to SOC. This study will include an initial single participant dose-escalation part one followed by a multiple participant dose-escalation part two with the possibility of expansion.

NCT ID: NCT04550468 Completed - Dietary Habits Clinical Trials

Low-carbohydrate Versus Low-fat Breakfast in Type 2 Diabetes

Start date: October 1, 2020
Phase: N/A
Study type: Interventional

The prevalence of type 2 diabetes (T2D) is increasing worldwide, with ~380 M currently suffering from this chronic, debilitating disease. T2D is characterized by high blood glucose levels in the mornings and after meals. The largest hyperglycemic spike often occurs after breakfast. Targeting this meal may be a simple, feasible strategy to improve glycemic control and reduce risk for diabetes complications. It is hypothesized that consuming a low carbohydrate high fat (LCHF) breakfast for 3 months, when compared to a standard low-fat breakfast will improve blood glucose control, increase satiety and improve body composition in people with T2D. This information will test whether the simple dietary strategy of limiting carbohydrates at breakfast could help in managing T2D.

NCT ID: NCT04549974 Completed - Healthy Clinical Trials

Characterization of Myocardial Blood Flow During Heat Exposure

PET-Heat
Start date: August 25, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the increase in myocardial blood flow during heat exposure and how this response is affected by age and coronary artery disease.